Darshak Sanghavi to Cardiovascular Diseases
This is a "connection" page, showing publications Darshak Sanghavi has written about Cardiovascular Diseases.
Connection Strength
0.793
-
Sanghavi DM, Conway PH. Approaches to Prevention of Cardiovascular Disease--Reply. JAMA. 2015 Dec 01; 314(21):2306-7.
Score: 0.284
-
Sanghavi DM, Conway PH. Paying for Prevention: A Novel Test of Medicare Value-Based Payment for Cardiovascular Risk Reduction. JAMA. 2015 Jul 14; 314(2):123-4.
Score: 0.276
-
Engelgau MM, Narayan KMV, Ezzati M, Salicrup LA, Belis D, Aron LY, Beaglehole R, Beaudet A, Briss PA, Chambers DA, Devaux M, Fiscella K, Gottlieb M, Hakkinen U, Henderson R, Hennis AJ, Hochman JS, Jan S, Koroshetz WJ, Mackenbach JP, Marmot MG, Martikainen P, McClellan M, Meyers D, Parsons PE, Rehnberg C, Sanghavi D, Sidney S, Siega-Riz AM, Straus S, Woolf SH, Constant S, Creazzo TL, de Jesus JM, Gavini N, Lerner NB, Mishoe HO, Nelson C, Peprah E, Punturieri A, Sampson U, Tracy RL, Mensah GA. Implementation Research to Address the United States Health Disadvantage: Report of a National Heart, Lung, and Blood Institute Workshop. Glob Heart. 2018 06; 13(2):65-72.
Score: 0.084
-
Lloyd-Jones DM, Huffman MD, Karmali KN, Sanghavi DM, Wright JS, Pelser C, Gulati M, Masoudi FA, Goff DC. Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology. Circulation. 2017 Mar 28; 135(13):e793-e813.
Score: 0.076
-
Karmali KN, Lloyd-Jones DM, Berendsen MA, Goff DC, Sanghavi DM, Brown NC, Korenovska L, Huffman MD. Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews. JAMA Cardiol. 2016 06 01; 1(3):341-9.
Score: 0.073